rec. | Subject | Hit Length | Description | Align.Len | E value | Bit score | % ident. | % pos. | GO associations |
241 | P50197 | 250 | LINC_PSEPA 2,5-dichloro-2,5-cyclohexadiene-1,... | 260 | 4e-16 | 79 | 28 | 45 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW.::GO:0009636; P:response to toxin; IEA:UniProtKB-KW. | 242 | A4IFA7 | 237 | CBR4_BOVIN Carbonyl reductase family member 4... | 249 | 4e-16 | 78.6 | 29 | 44 | GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell. | | | | | | | | | | | | | | | | | | | | GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW. | 243 | Q9VXJ0 | 598 | DHB4_DROME Peroxisomal multifunctional enzyme... | 188 | 4e-16 | 81.3 | 29 | 47 | GO:0005777; C:peroxisome; IC:FlyBase. | | | | | | | | | | GO:0080023; F:3R-hydroxyacyl-CoA dehydratase activity; IDA:FlyBase.::GO:0004300; F:enoyl-CoA hydratase activity; IDA:FlyBase.::GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IEA:EC.::GO:0042803; F:protein homodimerization activity; IDA:FlyBase. | | | | | | | | | | GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; IC:FlyBase. | 244 | Q4A054 | 234 | Y0419_STAS1 Uncharacterized oxidoreductase SS... | 192 | 4e-16 | 78.2 | 30 | 47 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 245 | Q4L8Y1 | 231 | Y0585_STAHJ Uncharacterized oxidoreductase SH... | 234 | 5e-16 | 78.2 | 25 | 46 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 246 | P50162 | 273 | TRN1_DATST Tropinone reductase 1 OS=Datura st... | 256 | 5e-16 | 78.6 | 27 | 44 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0050356; F:tropine dehydrogenase activity; IEA:EC. | | | | | | | | | | | 247 | P27582 | 201 | FABG6_BRANA 3-oxoacyl-[acyl-carrier-protein] ... | 175 | 6e-16 | 77.4 | 31 | 49 | GO:0009507; C:chloroplast; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0004316; F:3-oxoacyl-[acyl-carrier-protein reductase (NADPH) activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW.] | 248 | P52037 | 247 | YGFF_ECOLI Uncharacterized oxidoreductase ygf... | 259 | 8e-16 | 77.8 | 29 | 49 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 249 | P25145 | 248 | Y432_LISMO Uncharacterized oxidoreductase Lmo... | 232 | 0.000000000000001 | 77.4 | 28 | 48 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 250 | P50165 | 268 | TRNH_DATST Tropinone reductase homolog OS=Dat... | 251 | 0.000000000000001 | 77.4 | 26 | 44 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 251 | Q8VCC1 | 269 | PGDH_MOUSE 15-hydroxyprostaglandin dehydrogen... | 248 | 0.000000000000001 | 77.4 | 30 | 47 | GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; ISS:UniProtKB.::GO:0070403; F:NAD+ binding; ISS:UniProtKB.::GO:0004957; F:prostaglandin E receptor activity; ISS:UniProtKB. | | | | | | | | | | GO:0097070; P:ductus arteriosus closure; IMP:UniProtKB.::GO:0007565; P:female pregnancy; ISS:UniProtKB.::GO:0045786; P:negative regulation of cell cycle; ISS:UniProtKB.::GO:0030728; P:ovulation; ISS:UniProtKB.::GO:0007567; P:parturition; ISS:UniProtKB.::GO:0006693; P:prostaglandin metabolic process; ISS:UniProtKB.::GO:0070493; P:thrombin receptor signaling pathway; ISS:UniProtKB.::GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISS:UniProtKB. | 252 | Q5HLD8 | 230 | Y2049_STAEQ Uncharacterized oxidoreductase SE... | 216 | 0.000000000000003 | 75.9 | 27 | 49 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 253 | Q8CN40 | 230 | Y2036_STAES Uncharacterized oxidoreductase SE... | 216 | 0.000000000000003 | 75.9 | 27 | 49 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 254 | Q9MYP6 | 270 | DHB14_BOVIN 17-beta-hydroxysteroid dehydrogen... | 183 | 0.000000000000003 | 76.3 | 30 | 52 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | | 255 | P70684 | 265 | PGDH_CAVPO 15-hydroxyprostaglandin dehydrogen... | 200 | 0.000000000000003 | 76.3 | 31 | 49 | GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; ISS:UniProtKB.::GO:0070403; F:NAD+ binding; ISS:UniProtKB.::GO:0004957; F:prostaglandin E receptor activity; ISS:UniProtKB. | | | | | | | | | | GO:0097070; P:ductus arteriosus closure; ISS:UniProtKB.::GO:0007565; P:female pregnancy; ISS:UniProtKB.::GO:0045786; P:negative regulation of cell cycle; ISS:UniProtKB.::GO:0030728; P:ovulation; ISS:UniProtKB.::GO:0007567; P:parturition; ISS:UniProtKB.::GO:0006693; P:prostaglandin metabolic process; ISS:UniProtKB.::GO:0070493; P:thrombin receptor signaling pathway; ISS:UniProtKB.::GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISS:UniProtKB. | 256 | Q04520 | 241 | BUDC_RAOTE Diacetyl reductase [(S)-acetoin fo... | 220 | 0.000000000000005 | 75.5 | 26 | 44 | | | | | | | | | | | GO:0052588; F:diacetyl reductase ((S)-acetoin forming) activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0045150; P:acetoin catabolic process; IEA:InterPro. | 257 | O70351 | 261 | HCD2_RAT 3-hydroxyacyl-CoA dehydrogenase type... | 262 | 0.000000000000006 | 75.5 | 29 | 46 | | | | | | | | | | | GO:0047015; F:3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity; IEA:EC.::GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; IEA:EC.::GO:0018454; F:acetoacetyl-CoA reductase activity; IDA:RGD.::GO:0001540; F:beta-amyloid binding; IDA:RGD.::GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IDA:RGD.::GO:0030331; F:estrogen receptor binding; IPI:RGD.::GO:0042802; F:identical protein binding; IDA:RGD.::GO:0051287; F:NAD binding; IDA:RGD.::GO:0005496; F:steroid binding; IDA:RGD. | | | | | | | | | | GO:0007569; P:cell aging; IEP:RGD.::GO:0033327; P:Leydig cell differentiation; IEP:RGD.::GO:0051289; P:protein homotetramerization; IDA:RGD.::GO:0008033; P:tRNA processing; IEA:UniProtKB-KW. | 258 | Q9GME3 | 134 | DHB8_CALJA Estradiol 17-beta-dehydrogenase 8 ... | 138 | 0.000000000000007 | 73.2 | 36 | 54 | GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0004303; F:estradiol 17-beta-dehydrogenase activity; ISS:UniProtKB.::GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0050327; F:testosterone 17-beta-dehydrogenase (NAD+) activity; IEA:EC. | | | | | | | | | | GO:0006703; P:estrogen biosynthetic process; ISS:UniProtKB.::GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW. | 259 | P55435 | 248 | Y4EL_RHISN Uncharacterized short-chain type d... | 253 | 0.000000000000008 | 75.1 | 25 | 44 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 260 | O02691 | 261 | HCD2_BOVIN 3-hydroxyacyl-CoA dehydrogenase ty... | 262 | 0.000000000000009 | 74.7 | 29 | 47 | | | | | | | | | | | GO:0047015; F:3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity; IEA:EC.::GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0008033; P:tRNA processing; IEA:UniProtKB-KW. | 261 | Q9WV68 | 292 | DECR2_MOUSE Peroxisomal 2,4-dienoyl-CoA reduc... | 265 | 0.00000000000001 | 75.1 | 28 | 46 | GO:0005777; C:peroxisome; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0008670; F:2,4-dienoyl-CoA reductase (NADPH) activity; ISS:UniProtKB.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0006636; P:unsaturated fatty acid biosynthetic process; ISS:UniProtKB. | 262 | P15428 | 266 | PGDH_HUMAN 15-hydroxyprostaglandin dehydrogen... | 225 | 0.00000000000001 | 74.7 | 29 | 48 | GO:0005829; C:cytosol; NAS:UniProtKB.::GO:0005634; C:nucleus; IDA:HPA. | | | | | | | | | | GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; IDA:UniProtKB.::GO:0070403; F:NAD+ binding; IDA:UniProtKB.::GO:0004957; F:prostaglandin E receptor activity; IDA:UniProtKB.::GO:0042803; F:protein homodimerization activity; TAS:UniProtKB. | | | | | | | | | | GO:0097070; P:ductus arteriosus closure; ISS:UniProtKB.::GO:0007565; P:female pregnancy; IDA:UniProtKB.::GO:0019372; P:lipoxygenase pathway; TAS:UniProtKB.::GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB.::GO:0030728; P:ovulation; ISS:UniProtKB.::GO:0007567; P:parturition; IDA:UniProtKB.::GO:0006693; P:prostaglandin metabolic process; IDA:UniProtKB.::GO:0070493; P:thrombin receptor signaling pathway; ISS:UniProtKB.::GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB. | 263 | O34782 | 263 | YVRD_BACSU Uncharacterized oxidoreductase yvr... | 265 | 0.00000000000001 | 74.7 | 25 | 45 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 264 | Q02207 | 900 | FOX2_YEAST Peroxisomal hydratase-dehydrogenas... | 189 | 0.0000004 | 54.3 | 30 | 45 | GO:0005777; C:peroxisome; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; IDA:SGD.::GO:0004300; F:enoyl-CoA hydratase activity; IDA:SGD.::GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0006635; P:fatty acid beta-oxidation; IMP:SGD. | 265 | P16544 | 261 | ACT3_STRCO Putative ketoacyl reductase OS=Str... | 266 | 0.00000000000001 | 74.3 | 27 | 45 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW. | 266 | P0A169 | 259 | NAHB_PSEPU 1,2-dihydroxy-1,2-dihydronaphthale... | 270 | 0.00000000000001 | 74.3 | 26 | 45 | | | | | | | | | | | GO:0018505; F:cis-1,2-dihydro-1,2-dihydroxynaphthalene dehydrogenase activity; IEA:EC.::GO:0018513; F:dibenzothiophene dihydrodiol dehydrogenase activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW. | 267 | P0A170 | 259 | NAHB_PSEU8 1,2-dihydroxy-1,2-dihydronaphthale... | 270 | 0.00000000000002 | 74.3 | 26 | 45 | | | | | | | | | | | GO:0018505; F:cis-1,2-dihydro-1,2-dihydroxynaphthalene dehydrogenase activity; IEA:EC.::GO:0018513; F:dibenzothiophene dihydrodiol dehydrogenase activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW. | 268 | Q23116 | 309 | YWC4_CAEEL Uncharacterized oxidoreductase W01... | 253 | 0.00000000000002 | 74.7 | 26 | 47 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | GO:0019915; P:lipid storage; IMP:WormBase. | 269 | Q68ER2 | 236 | CBR4_XENTR Carbonyl reductase family member 4... | 169 | 0.00000000000002 | 73.6 | 33 | 47 | GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW. | 270 | Q01373 | 894 | FOX2_NEUCR Peroxisomal hydratase-dehydrogenas... | 116 | 0.0000000004 | 63.2 | 31 | 52 | GO:0005777; C:peroxisome; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.::GO:0016829; F:lyase activity; IEA:UniProtKB-KW.::GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IEA:EC. | | | | | | | | | | GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW. | 271 | Q8MJY8 | 266 | PGDH_MACFA 15-hydroxyprostaglandin dehydrogen... | 223 | 0.00000000000003 | 73.6 | 29 | 48 | GO:0005737; C:cytoplasm; IDA:UniProtKB. | | | | | | | | | | GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; ISS:UniProtKB.::GO:0070403; F:NAD+ binding; ISS:UniProtKB.::GO:0004957; F:prostaglandin E receptor activity; ISS:UniProtKB. | | | | | | | | | | GO:0097070; P:ductus arteriosus closure; ISS:UniProtKB.::GO:0007565; P:female pregnancy; ISS:UniProtKB.::GO:0045786; P:negative regulation of cell cycle; ISS:UniProtKB.::GO:0030728; P:ovulation; IEP:UniProtKB.::GO:0007567; P:parturition; ISS:UniProtKB.::GO:0006693; P:prostaglandin metabolic process; ISS:UniProtKB.::GO:0070493; P:thrombin receptor signaling pathway; ISS:UniProtKB.::GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISS:UniProtKB. |